FindTrial
Sign In

STUDY ON THE USE OF MIFEPRISTONE AND MISOPROSTOL

ACCEPTABILITY OF MIFEPRISTONE AND MISOPROSTOL DURING FIRST TRIMESTER PREGNANCY MEDICAL TERMINATION OF PREGNANCY AT A TERTIARY CARE HOSPITAL. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/079669
Enrollment
35
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complications

Interventions

None listed

Sponsors

Sri Ramachandra Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women who seeking Medical Termination of Pregnancy at First-trimester gestation. 2.Women seeking medical termination of pregnancy and providing informed consent. 3.Patient undergo MTP as family planning and medical needs.

Exclusion criteria

Exclusion criteria: 1. Ectopic Pregnancy 2. Intrauterine pregnancy more than 63 days of gestation 3. Unmarried pregnancy 4. Any previous attempts at terminating the present pregnancy, coagulation disorders, uncontrolled hypertension and anaemia with Hb greater than 8 gm percentage.

Design outcomes

Primary

MeasureTime frame
Determine the acceptability of mifepristone and misoprostol among patients during First trimester pregnancy termination.Timepoint: 7 14 days—

Secondary

MeasureTime frame
1. Ensure the safety & efficacy profile of Mifepristone & Misoprostol in Medical Termination of Pregnancy. 2. Assess the effectiveness of these drugs in various gravidity. 3. Investigate any potential risks or adverse effects associated with their use in first trimester pregnancy termination.Timepoint: 7-14 Days—

Countries

India

Contacts

Public ContactDr G Dhanalakshmi

SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH

amb@sriramachandra.edu.in9488588735

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026